Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
companyunderground
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Emflaza
Emflaza
Why PTC Therapeutics Dropped 30.6% Today After Jumping 27.5% Yesterday
Motley Fool
Tue, 06/19/18 - 10:42 pm
PTC Therapeutics
risdiplam
Biogen
Ionis Pharmaceuticals
spinal muscular atrophy
Sarepta Therapeutics
Translarna
Emflaza
How Big Pharma Might Be Cut Down To Size
Forbes
Thu, 05/11/17 - 06:34 pm
Big Pharma
drug pricing
Emflaza
Marathon Pharma
PTC to launch DMD drug with still high price tag
BioPharma Dive
Wed, 05/10/17 - 09:47 am
PTC Therapeutics
drug pricing
Duchenne Muscular Dystrophy
Emflaza
Payer snubs PTC's Emflaza, signaling pricing trouble ahead of launch
Fierce Pharma
Sat, 04/15/17 - 09:27 am
PTC Therapeutics
Emflaza
drug launches
drug pricing
Duchenne Muscular Dystrophy
PTC comes under fire from Congress for Emflaza
BioPharma Dive
Wed, 03/22/17 - 10:39 pm
PTC Therapeutics
Emflaza
drug pricing
congress
After being spurned at the FDA, PTC buys a controversial Duchenne MD therapy from Marathon
Endpoints
Thu, 03/16/17 - 09:48 am
FDA
PTC Therapeutics
Duchenne Muscular Dystrophy
Emflaza
Marathon Pharma
Eight senators pile on to Marathon's Emflaza—and its $89,000 pricing blunder
Fierce Pharma
Mon, 03/6/17 - 11:55 am
Senate
Marathon Pharma
Emflaza
drug pricing
Marathon halts launch of DMD drug as $89K price attracts congressional heat
Fierce Pharma
Tue, 02/14/17 - 12:12 pm
Marathon Pharma
Duchenne Muscular Dystrophy
drug pricing
Bernie Sanders
Emflaza
The scoop: Marathon’s R&D program for Duchenne MD drug likely came in at a bargain basement price
Endpoints
Mon, 02/13/17 - 10:00 am
Marathon Pharma
R&D
Duchenne Muscular Dystrophy
Emflaza
Why Did That Drug Price Increase 6,000%? It's The Law
Forbes
Sat, 02/11/17 - 12:40 pm
drug pricing
deflazacort
generics
Duchenne Muscular Dystrophy
Emflaza
Marathon Pharma
FDA approves Marathon Pharma's Duchenne muscular dystrophy drug
Marketwatch
Thu, 02/9/17 - 09:29 pm
FDA
Marathon Pharma
Duchenne Muscular Dystrophy
Emflaza